Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Menzella

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Journal of Medical Economics|December 19, 2025
The biologic paradox solved? The imminent arrival of omalizumab biosimilars in EuropeFrancesco Menzella
Journal of Medical Economics|April 22, 2026
Integrating single-inhaler triple therapy into global asthma management: clinical breakthroughs and economic realitiesFrancesco Menzella
Journal of Clinical Medicine|February 25, 2023
Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of OutcomesFrancesco Menzella
Expert Opinion on Biological Therapy|March 24, 2026
Dual clinical remission in severe asthma and chronic rhinosinusitis with nasal polyps: a comparative review of biologic therapiesCarlo Lombardi, Francesco Menzella
Expert Review of Clinical Immunology|June 17, 2025
Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?Carlo Lombardi, Francesco Menzella
Expert Review of Respiratory Medicine|April 3, 2026
Time for proper physiological assessment: the role of cardiopulmonary exercise testing in helping step-up therapy in difficult-to-treat and severe asthmaAriel Fabian Floriani, Francesco Menzella
The Journal of International Medical Research|November 5, 2025
Unraveling the obesity-asthma link: A new horizon with glucagon-like peptide-1 receptor agonists in a complex intersection of metabolism and airway diseaseFrancesco Menzella, Marcello Cottini, Rory Chan
Drugs in Context|July 29, 2024
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case seriesCarlo Lombardi, Francesco Menzella, Alvise Berti
Respiratory Medicine Case Reports|December 5, 2019
Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reportsCarlo Lombardi, Francesco Menzella, Giovanni Passalacqua
Drugs in Context|September 4, 2025
Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective studyCarlo Lombardi, Alvise Berti, Francesco Menzella, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Journal of Medical Economics|December 19, 2025
The biologic paradox solved? The imminent arrival of omalizumab biosimilars in EuropeFrancesco Menzella
Journal of Medical Economics|April 22, 2026
Integrating single-inhaler triple therapy into global asthma management: clinical breakthroughs and economic realitiesFrancesco Menzella
Journal of Clinical Medicine|February 25, 2023
Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of OutcomesFrancesco Menzella
Expert Opinion on Biological Therapy|March 24, 2026
Dual clinical remission in severe asthma and chronic rhinosinusitis with nasal polyps: a comparative review of biologic therapiesCarlo Lombardi, Francesco Menzella
Expert Review of Clinical Immunology|June 17, 2025
Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?Carlo Lombardi, Francesco Menzella
Expert Review of Respiratory Medicine|April 3, 2026
Time for proper physiological assessment: the role of cardiopulmonary exercise testing in helping step-up therapy in difficult-to-treat and severe asthmaAriel Fabian Floriani, Francesco Menzella
The Journal of International Medical Research|November 5, 2025
Unraveling the obesity-asthma link: A new horizon with glucagon-like peptide-1 receptor agonists in a complex intersection of metabolism and airway diseaseFrancesco Menzella, Marcello Cottini, Rory Chan
Drugs in Context|July 29, 2024
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case seriesCarlo Lombardi, Francesco Menzella, Alvise Berti
Respiratory Medicine Case Reports|December 5, 2019
Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reportsCarlo Lombardi, Francesco Menzella, Giovanni Passalacqua
Drugs in Context|September 4, 2025
Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective studyCarlo Lombardi, Alvise Berti, Francesco Menzella, et al.
Pageof 14